administered intravenously and he was transferred to theatre.
After preoxygenation, thiopentone 350 mg and suxamethonium 100 mg were administered and intubation performed with cricoid pressure. Pancuronium 6 mg was then administered and anaesthesia maintained with nitrous oxide, oxygen and narcotic supplement. A further 2 mg of pancuronium was required 80 minutes after the commencement of surgery. Anaesthesia was uneventful. Systolic blood pressure was maintained at approximately 100 mmHg and central venous pressure at approximately 10 cm H20. Urine output was satisfactory.
Laparotomy revealed: 1. free peritoneal bile, secondary to a large duodenal perforation, 2. obstruction of the duodenal flexure 3. evidence of severe pancreatitis, 4. pancreati~ pseudocyst, and 5. gallstones. Peritoneal lavage, cholecystostomy, duodenostomy, gastroenterostomy and jejunostomy were performed.
After two and a half hours of surgery, neuromuscular blockade was reversed with neostigmine 5 mg and atropine 1.2 mg. The patient was awake, with good muscle power and breathing well on transfer to the Intensive Care Unit. A morphine infusion was commenced at 2 mg/hour. Intravenous quinine was considered necessary in view of questionable absorption of previous oral doses and persisting parasites on blood film. His general condition was stable when, 1 Y2 hours postoperatively, an intravenous infusion of 500 mg quinine, in isotonic saline 500 ml (to run over 6 hours) was commenced.
Within ten minutes the patient became dyspnoeic and respiration quickly became totally ineffective. Systolic blood pressure dropped to 60 mmHg. Both morphine and quinine infusions were ceased and naloxone 0.2 mg was given without effect. Blood pressure was rapidly restored with intravenous infusion of fluids. He was intubated after thiopentone 100 mg and suxamethonium 75 mg as paralysis was profound but not complete. Flaccidity persisted for three hours and then strength gradually returned. Electrolytes after reintubation showed that the urea had fallen to 8.6 mmolll and others were essentially unchanged. Creatinine was not available but two days later was 0.1 mmolll. No electrophysiological tests of muscle function were performed but the clinical impression was one of recurarization.
There were no further problems with ventilation and the patient was extubated several days later. Quinine was withheld and recommenced via jejunostomy after extubation. A summary of the relevant drug and clinical history appear in Table 1 .
Relaxant/narcotic anaesthesia for drainage of an intra-abdominal abscess ten days later was uneventful, as was the immediate postoperative course.
DISCUSSION
Quinine is one of the cinchona alkaloids, a group of drugs with well documented effects on muscle.! They interfere with neuromuscular Urea 8.9 mmoIll Urea 8.0 mmol/l Creatinine 0.10 mmoIll transmission by decreasing motor end plate excitability, a curare-like effect, and by increasing the refractory period of muscle thereby reducing the response to tetanic stimulation. Animal studies have demonstrated the interaction between quinidine and both depolarising and non-depolarising relaxants 2 ,3 with an increase in both duration and intensity of blockade reported.
Recurarization has been reported with the use of quinidine after reversal of neurom uscular blockade. 4 Quinine (the I-optical isomer of quinidine) would appear to have the same potential for such interactions. It has been used in the treatment of myotonia and has been known to precipitate myasthenia gravis. s However, no reports of interactions with muscle relaxants appear in the literature.
Quinine is well absorbed orally from the upper small intestine with peak plasma concentrations within one to three hours of a single dose. Plasma levels fall rapidly after cessation of therapy, due to metabolic degradation by the liver.
In the case reported, no quinine had been administered for approximately ten hours prior to reversal of pancuronium and vomiting had been severe for the previous 24 hours, and only approximately 15 mg of quinine had been given intravenously before the respiratory arrest.
It is possible that a second drug effect exists here. Gentamicin 80 mg was administered AnaeSfilesia and InJensive Care. Vol. I I, No. 3, August, 1983 intravenously five hours prior to commencement of the quinine infusion. Aminoglycoside antibiotics are generally considered to produce neuromuscular block by inhibiting presynaptic acetylcholine release and depressing the postjunctional membrane sensitivity.5,6 True potentiation of the effects of muscle relaxants by aminoglycosides has been demonstrated 7 and there are numerous reports of recurarization following aminoglycoside administration after anaesthesia,6,8,9
Five hours after a single bolus injection of gentamicin, plasma levels would be expected to have little effect on neuromuscular block. However, in this case, impaired renal excretion may have resulted in higher than expected levels.
The narcotic infusion had only been running for 30 minutes at a rate of 2 mg/hr (no bolus dose had been given), The problem was ineffectual respiration rather than apnoea, and there was no response to intravenous naloxone 0.2 mg. Thus the narcotic is extremely unlikely to have played a significant role.
Since, in this case neuromuscular blockade had been adequately reversed prior to the commencement of the quinine infusion we consider it to be the cause of recurarization. However, the prior use of gentamicin and oral quinine may have reduced the margin of safety at the neuromuscular junction considerably. This is proffered as an explanation for such Anaesthesia and Intensive Care, Vol. 11, No. 3, Augusl, 1983 profound respiratory depression with such a small dose of quinine.
